date:Jan 22, 2013
Novozymes has reported organic sales growth of 4% (7% DKK, 3% local currency) for 2012 compared with 201, with sales rising to DKK 11,234 million. EBIT increased by 17%, raising the EBIT margin to 24.4%. Net profit grew by 10%. The company said that, for 2013, the EBIT margin is expected to remain at its current high level, while organic sales growth is expected to increase to 5-8%.
Concurrently, the company announced that Peder Holk Nielsen will succeed Steen Riisgaard as president and CEO on